Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2018-08-07 Earnings Release
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filing dated August 7, 2018, by Avanos Medical, Inc. It announces the results of operations for the three and six months ended June 30, 2018, referencing a press release attached as Exhibit 99.1. The text indicates this is a current report announcing financial results via a press release, not the full financial report itself. The document length is short (2808 characters), and it primarily serves as a notification of earnings results rather than containing detailed financial statements or analysis. Therefore, it fits the definition of an Earnings Release (ER) rather than an Interim Report (IR) or Annual Report (10-K).
2018-08-07 English
FORM 4
Director's Dealing
2018-06-28 English
FORM 8-K
Report Publication Announcement Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated June 21, 2018. It specifically mentions "Item 7.01 Regulation FD Disclosure" where the company states it will make certain financial materials available in conjunction with hosting its Analyst and Investor Conference on June 21, 2018. It also references Exhibit 99.1 as the Analyst and Investor Conference Presentations. The document itself is a short filing (3425 characters) that announces the availability of the presentation materials rather than containing the full presentation or detailed financial data. According to the "Menu vs Meal" rule, this is an announcement of a report (the presentation) rather than the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2018-06-21 English
FORM 4
Director's Dealing
2018-06-04 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 29, 2018. It announces amendments to the company's Certificate of Incorporation and bylaws to change the company name from 'Halyard Health, Inc.' to 'Avanos Medical, Inc.' effective June 30, 2018. It also references a press release about the name change. The content is about corporate governance changes (name change via amendments to incorporation documents and bylaws) and does not contain financial statements or detailed financial data. It is not an annual or quarterly report, earnings release, or other financial report. The primary focus is on board-level corporate changes (amendments to articles and bylaws). Therefore, the best fitting category is Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management or related corporate governance changes such as amendments to incorporation documents.
2018-06-01 English
FORM SD CONFLICT MINERALS
Regulatory Filings Classification · 95% confidence The document is a Form SD filing with the SEC, specifically a Specialized Disclosure Report related to conflict minerals for the year ended December 31, 2017. It references the Conflict Minerals Report as an exhibit but does not contain full financial statements or detailed financial performance data. The document length is 4571 characters, which is relatively short and primarily serves as a regulatory disclosure rather than a comprehensive report. Form SD filings are specialized regulatory disclosures required by the SEC and do not fall under Annual Reports, Interim Reports, or other financial filings. Therefore, this document fits best under Regulatory Filings (RNS) as a specialized disclosure report.
2018-05-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.